More than 180 mutations have been found in the Aβ generating γ‐secretases, PSEN1 & PSEN2, which historically made them promising and intensely studied targets for potentially reducing Aβ accumulation in brains of AD patients. This evidence concerns the gene PSEN1 and Alzheimer disease.